Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALIVUS LIFE SCIENCES LIMITED Call Transcript 2022

Feb 1, 2022

59201_rns_2022-02-01_948e56f5-9a5b-4187-9702-0d4f47690e84.pdf

Call Transcript

Open in viewer

Opens in your device viewer

February 1, 2022

To, To,
Dy. General Manager The Manager –Listing,
Department of Corporate Services, National Stock Exchange of India Ltd.,
BSE Ltd., Plot No. C/1, G Block,
P. J. Towers, Dalal Street, Bandra Kurla Complex,
Fort, Mumbai –400 001 Bandra (E), Mumbai –400 051

Ref: Scrip Code: 543322 Ref: Scrip Name: GLS

Dear Sirs,

Enclosed please find herewith the details of Earnings Call slated for Wednesday, February 9, 2022 at 8:30 a.m. – 9:30 a.m. (IST), for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.

Thanking you.

Yours faithfully, For Glenmark Life Sciences Limited

RUDALF JOSEPH CORRIEA Digitally signed by RUDALF JOSEPH CORRIEA Date: 2022.02.01 20:14:17 +05'30'

Rudalf Corriea Company Secretary & Compliance Officer

Encl: As above

I N V I T A T I O N

Glenmark Life Sciences Ltd. Q3 FY 2021 – 22 Result Earnings Call

Date: Wednesday, February 9, 2022

Time: 8:30 am – 9:30 am [IST]

Dial – in Numbers:

Universal Access Number:

+91 22 6280 1564

+91 22 7115 8394

International Toll Free:

Australia 1800053698 Canada 01180014243444 China 4008428405 Hong Kong 800964448 Italy 0080014243444 Japan 00531161110 Singapore 8001012045 South Korea 00180014243444 UK 08081011573 USA 18667462133

International Toll:

HongKong +852 30186877
Japan +81 345899421
Singapore +65 31575746
SouthAfrica +27 110623033
UK +44 2034785524
USA +1 3233868721

To pre-register online, please click here

For any clarification, please contact:

Soumi Rao

E-mail: [email protected]

Phone: [+91 9870196931]